RHD and myasthenia gravis: Recommended for neonates born to mothers with toxemia or diabetes to mitigate the risk of polycythemia, and in instances to limit the transmission of antibodies and viruses to the fetus, notably in cases of hemolytic disease due to maternal immunization against RhD antigen, myasthenia gravis, or maternal viral diseases like HIV and CMV.